A Study of the Effects of RoActemra/Actemra (Tocilizumab) on Neutrophils in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic and/or Non-biologic DMARDs.
Condition: Rheumatoid Arthritis Intervention: Drug: tocilizumab [RoActemra/Actemra] Sponsor: Hoffmann-La Roche Not yet recruiting - verified July 2011